Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026
The global market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. Foodborne illnesses have affected socioeconomic development by straining health care systems and trade. The factors fueling the growth of the enteric disease testing market are the implementation of stringent regulations related to contaminant detection, growth in consumer awareness, and humid atmospheric conditions, which are leading to an increase in contamination in food. In order to address enteric disease concerns, caused by foodborne illness, skey players in the various regions will need to further improve upon their food safety monitoring programs.
The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.
The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.
By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market.
Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders.
The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.
Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood products
The North American region is estimated to account for the largest market share in the global enteric disease testing market.
The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.
Break-up of Primaries
This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.
Reasons to buy this report
The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.
The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.
By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market.
Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders.
The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.
Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood products
The North American region is estimated to account for the largest market share in the global enteric disease testing market.
The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.
Break-up of Primaries
- By Company Type: Tier 1: 65%, Tier 2: 20%, and Tier 3: 15%
- By Designation: C-Level – 45%, Director Level – 30%, others- 25%
- By Region: North America – 10%, Europe – 45%, Asia Pacific – 25%, South America – 5%, and Rest of the World (RoW) – 15%.
- SGS SA (Switzerland)
- Eurofins Scientific (Luxembourg)
- Intertek Group plc (UK)
- Bureau Veritas (France)
- ALS Limited (Australia)
- T?V S?D (Germany)
- NEOGEN Corporation (US)
- M?rieux NutriSciences (US)
- AsureQuality (New Zealand)
This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.
Reasons to buy this report
- To get a comprehensive overview of the enteric disease testing market
- To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them.
- To gain insights about the major countries/regions, in which the enteric disease testing market is flourishing.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION
1.3.1 REGIONAL SEGMENTATION
1.4 INCLUSIONS & EXCLUSIONS
1.4.1 PERIODIZATION CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2015–2019
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE
FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020
2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19
2.7 SCENARIO-BASED MODELLING
2.8 COVID-19 HEALTH ASSESSMENT
FIGURE 7 COVID-19: GLOBAL PROPAGATION
FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES
2.9 COVID-19 ECONOMIC ASSESSMENT
FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020
2.9.1 COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT
FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY
FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET
4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY
4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020
4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT
4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN FOODBORNE ILLNESSES
FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)
FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020
5.3 MARKET DYNAMICS
FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increase in the number of food recalls
FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017–2020
FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020
5.3.1.2 Rise in demand for convenience foods
FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020
FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT)
5.3.1.3 Increase in global trade owing to higher disposable income among consumers
FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 2016–2018 (USD BILLION)
FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)
5.3.2 RESTRAINTS
5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies
5.3.3 OPPORTUNITIES
5.3.3.1 Technological innovations in the food safety testing industry
5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing
TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES
5.3.4 CHALLENGES
5.3.4.1 High cost associated with testing of food and water
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 REGULATORY FRAMEWORK
6.2.1 INTRODUCTION
6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS
6.2.2.1 Codex Alimentarius Commission (CAC)
6.2.2.2 Global Food Safety Initiative (GFSI)
6.2.3 NORTH AMERICA
6.2.3.1 US regulations
6.2.3.2 Mexico
6.2.3.3 Canada
6.2.4 EUROPE
6.2.4.1 Microbiological criteria regulation
6.2.4.2 General food law for food safety
6.2.4.3 Germany
6.2.4.4 UK
6.2.4.5 France
6.2.4.6 Italy
6.2.4.7 Poland
6.2.5 ASIA PACIFIC
6.2.5.1 China
TABLE 3 PATHOGEN LIMITS FOR FOOD
6.2.5.2 India
6.2.5.3 Japan
6.2.5.4 Australia
6.2.5.5 New Zealand
6.2.6 SOUTH AMERICA
6.2.6.1 Brazil
6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA)
6.2.6.3 Ministry of Health (MS)
6.2.6.4 Argentina
6.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
6.3.1 THREAT OF NEW ENTRANTS
6.3.2 THREAT OF SUBSTITUTES
6.3.3 BARGAINING POWER OF SUPPLIERS
6.3.4 BARGAINING POWER OF BUYERS
6.3.5 DEGREE OF COMPETITION
6.4 MARKET ECOSYSTEM
FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP
6.4.1 UPSTREAM
6.4.2 DOWNSTREAM
TABLE 5 COMPANY MARKET ECOSYSTEM
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET
6.5.1 R&D
6.5.2 PRODUCTION
6.5.3 PROCESSING & TRANSFORMING
6.5.4 TRANSPORTATION
6.5.5 FINAL PREPARATION
6.5.6 DISTRIBUTION
6.6 TECHNOLOGY ANALYSIS
6.7 PATENT ANALYSIS
FIGURE 33 PATENT ANALYSIS, 2017-2020
TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 2018- 2021
6.8 CASE STUDIES
TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION
6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET
FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES
6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS
6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT
6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY
7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
7.1 INTRODUCTION
FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021 VS. 2026 (USD MILLION)
TABLE 8 PATHOGENESIS OF COMMON PATHOGENS
FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019
TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019
TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
7.1.1.1 Realistic Scenario
TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1.2 Optimistic Scenario
TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1.3 Pessimistic Scenario
TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.2 E. COLI
7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning
FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–2018
FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)
TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.3 SALMONELLA
7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter
FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–2018
TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.4 CAMPYLOBACTER
7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness
FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018
TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.5 LISTERIA
7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen
TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.6 OTHER PATHOGENS
TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
8 ENTERIC DISEASE TESTING MARKET, BY END USE
8.1 INTRODUCTION
FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019
FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021 VS. 2026 (USD MILLION)
TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE
8.1.1.1 Realistic scenario
TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.1.1.2 Optimistic scenario
TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.1.1.3 Pessimistic scenario
TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.2 FOOD
8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING
TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS
FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017
TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES
TABLE 40 US: FOOD RECALLS, 2020
TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.2 MEAT, POULTRY, AND SEAFOOD
8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination
FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019
TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.3 DAIRY PRODUCTS
8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products
FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019
TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION)
TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION)
TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.4 PROCESSED FOOD
8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers
TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.5 FRUITS & VEGETABLES
8.2.5.1 Good handling practices can help in the safe production of fresh produce
TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2016–2020 (USD MILLION)
TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2021–2026 (USD MILLION)
TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.6 OTHER FOOD APPLICATIONS
TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2016–2020 (USD MILLION)
TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.3 WATER
8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS
TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2016–2020 (USD MILLION)
TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2021–2026 (USD MILLION)
TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2021–2026 (USD MILLION)
9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
9.1.1.1 Realistic scenario
TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1.2 Optimistic scenario
TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1.3 Pessimistic scenario
TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.2 TRADITIONAL
9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE
TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
9.3 RAPID
TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, BY REGION, 2016–2020 (USD MILLION)
TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2021–2026 (USD MILLION)
9.3.1 CONVENIENCE-BASED
9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions
9.3.2 POLYMERASE CHAIN REACTION (PCR)
9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms
9.3.3 IMMUNOASSAY
9.3.3.1 ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies
9.3.4 CHROMATOGRAPHY & SPECTROMETRY
9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry
10 ENTERIC DISEASE TESTING MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020
FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026
TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION
10.1.1.1 Realistic scenario
TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1.2 Optimistic scenario
TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1.3 Pessimistic scenario
TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.1 US
10.2.1.1 FSIS is the regulating body that enforces food safety regulations
FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018
FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016
TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)
FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016
TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety
TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.3 MEXICO
10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country
TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3 EUROPE
FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES
AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017
FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 International food trade has increased food safety risks
FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019
TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing
TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.3 SPAIN
10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry
TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Products of animal origin products are found to be more problematic in this region
TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.5 POLAND
10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety
TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENTS, 2016–2020 (USD MILLION)
TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.6 UK
10.3.6.1 Norovirus infection is estimated to occur every year in the UK
TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 E. coli to be the major pathogen found to affect people
TABLE 150 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 151 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 152 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 153 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Microbial contamination is reported to be the biggest food safety risk
TABLE 154 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 155 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 156 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 157 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 FSSAI to safeguard the quality of food produced
TABLE 158 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 159 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 160 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 161 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.4 AUSTRALIA & NEW ZEALAND
10.4.4.1 Gastroenteritis occurs every year, affecting several people
TABLE 162 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 163 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 164 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 165 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.5 THAILAND
10.4.5.1 Demand for food exports to boost the growth of the market
TABLE 166 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 167 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 168 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 169 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 170 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5 SOUTH AMERICA
TABLE 174 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 175 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 176 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 177 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 178 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION)
TABLE 179 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Export of agricultural produce to boost the demand for enteric disease testing
TABLE 180 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 181 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 182 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 183 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.2 ARGENTINA
10.5.2.1 Food companies are taking preventive measures for pathogen infections
TABLE 184 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 185 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 186 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 187 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.3 REST OF SOUTH AMERICA
TABLE 188 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 189 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 190 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 191 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6 REST OF THE WORLD (ROW)
TABLE 192 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
TABLE 193 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
TABLE 194 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 195 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 196 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 197 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6.1 SOUTH AFRICA
10.6.1.1 Growth in the demand to follow international standards is encouraging enteric disease testing
TABLE 198 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 199 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 200 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 201 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6.2 MIDDLE EAST
10.6.2.1 Food safety services are driven by food imports from other countries
TABLE 202 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 203 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 204 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 205 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET
11.3 MARKET SHARE ANALYSIS, 2020
FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS
11.4 COVID-19-SPECIFIC COMPANY RESPONSE
11.4.1 SGS SA
11.4.2 MERCK KGAA
11.4.3 EUROFINS SCIENTIFIC
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)
11.6 PRODUCT FOOTPRINT
TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY
TABLE 207 COMPANY FOOTPRINT, BY END-USE
TABLE 208 COMPANY FOOTPRINT, BY REGION
11.7 COMPANY EVALUATION QUADRANT (START-UP/SME)
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)
11.8 COMPETITIVE SCENARIO
11.8.1 NEW PRODUCTS LAUNCHES
TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019
11.8.2 DEALS
TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021
11.8.3 OTHER DEVELOPMENTS
TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, MAY 2018- JUNE 2021
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY COMPANIES
12.1.1 SGS SA
TABLE 212 SGS SA: BUSINESS OVERVIEW
FIGURE 59 SGS SA: COMPANY SNAPSHOT
TABLE 213 SGS SA: PRODUCT OFFERINGS
TABLE 214 SGA SA: DEALS
TABLE 215 SGS SA: OTHERS
12.1.2 MERCK KGAA
TABLE 216 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
TABLE 217 MERCK KGAA: PRODUCT OFFERINGS
12.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS
12.1.4 EUROFINS SCIENTIFIC
TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS
TABLE 223 EUROFINS SCIENTIFIC: DEALS
TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS
12.1.5 ALS LIMITED
TABLE 225 ALS LIMITED: BUSINESS OVERVIEW
FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT
TABLE 226 ALS LIMITED: PRODUCT OFFERINGS
TABLE 227 ALS LIMITED: DEALS
TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS
12.1.6 ASURE QUALITY
TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW
FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT
TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS
12.1.7 BUREAU VERITAS
TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW
FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT
TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS
12.1.8 INTERTEK
TABLE 233 INTERTEK: BUSINESS OVERVIEW
FIGURE 66 INTERTEK: COMPANY SNAPSHOT
TABLE 234 INTERTEK: PRODUCT OFFERINGS
TABLE 235 INTERTEK: DEALS
12.1.9 BIO-RAD LABORATORIES, INC.
TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
12.1.10 BECTON DICKINSON
TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW
FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT
TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS
12.1.11 3M
TABLE 240 3M: BUSINESS OVERVIEW
FIGURE 69 3M: COMPANY SNAPSHOT
TABLE 241 3M: PRODUCT OFFERINGS
12.1.12 PERKINELMER, INC.
TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS
12.1.13 NEOGEN CORPORATION
TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS
12.1.14 M?RIEUX NUTRISCIENCES
TABLE 246 M?RIEUX NUTRISCIENCES: BUSINESS OVERVIEW
TABLE 247 M?RIEUX NUTRISCIENCES: PRODUCT OFFERINGS
TABLE 248 M?RIEUX NUTRISCIENCES: DEALS
12.1.15 T?V S?D
TABLE 249 T?V S?D: BUSINESS OVERVIEW
TABLE 250 T?V S?D: PRODUCT OFFERINGS
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 HARDY DIAGNOSTICS
TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS
TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH
12.2.2 ROMER LABS
TABLE 254 ROMER LABS: BUSINESS OVERVIEW
TABLE 255 ROMER LABS: PRODUCT OFFERINGS
12.2.3 NOVA BIOLOGICALS
TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW
TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS
12.2.4 SYMBIO LABORATORIES
TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW
TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS
12.2.5 CERTIFIED LABORATORIES
13 ADJACENT AND RELATED MARKETS
13.1 INTRODUCTION
TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET
13.2 LIMITATIONS
13.3 FOOD PATHOGEN TESTING MARKET
13.3.1 MARKET DEFINITION
13.3.2 MARKET OVERVIEW
TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
13.4 FOOD TESTING KITS MARKET
13.4.1 MARKET DEFINITION
13.4.2 MARKET OVERVIEW
TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 2015–2022 (USD MILLION)
TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION)
13.5 MICROBIAL WATER TESTING MARKET
13.5.1 MARKET DEFINITION
13.5.2 MARKET OVERVIEW
TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION)
TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION
1.3.1 REGIONAL SEGMENTATION
1.4 INCLUSIONS & EXCLUSIONS
1.4.1 PERIODIZATION CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2015–2019
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE
FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020
2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19
2.7 SCENARIO-BASED MODELLING
2.8 COVID-19 HEALTH ASSESSMENT
FIGURE 7 COVID-19: GLOBAL PROPAGATION
FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES
2.9 COVID-19 ECONOMIC ASSESSMENT
FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020
2.9.1 COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT
FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY
FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET
4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY
4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020
4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT
4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN FOODBORNE ILLNESSES
FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)
FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020
5.3 MARKET DYNAMICS
FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increase in the number of food recalls
FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017–2020
FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020
5.3.1.2 Rise in demand for convenience foods
FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020
FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT)
5.3.1.3 Increase in global trade owing to higher disposable income among consumers
FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 2016–2018 (USD BILLION)
FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)
5.3.2 RESTRAINTS
5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies
5.3.3 OPPORTUNITIES
5.3.3.1 Technological innovations in the food safety testing industry
5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing
TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES
5.3.4 CHALLENGES
5.3.4.1 High cost associated with testing of food and water
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 REGULATORY FRAMEWORK
6.2.1 INTRODUCTION
6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS
6.2.2.1 Codex Alimentarius Commission (CAC)
6.2.2.2 Global Food Safety Initiative (GFSI)
6.2.3 NORTH AMERICA
6.2.3.1 US regulations
6.2.3.2 Mexico
6.2.3.3 Canada
6.2.4 EUROPE
6.2.4.1 Microbiological criteria regulation
6.2.4.2 General food law for food safety
6.2.4.3 Germany
6.2.4.4 UK
6.2.4.5 France
6.2.4.6 Italy
6.2.4.7 Poland
6.2.5 ASIA PACIFIC
6.2.5.1 China
TABLE 3 PATHOGEN LIMITS FOR FOOD
6.2.5.2 India
6.2.5.3 Japan
6.2.5.4 Australia
6.2.5.5 New Zealand
6.2.6 SOUTH AMERICA
6.2.6.1 Brazil
6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA)
6.2.6.3 Ministry of Health (MS)
6.2.6.4 Argentina
6.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
6.3.1 THREAT OF NEW ENTRANTS
6.3.2 THREAT OF SUBSTITUTES
6.3.3 BARGAINING POWER OF SUPPLIERS
6.3.4 BARGAINING POWER OF BUYERS
6.3.5 DEGREE OF COMPETITION
6.4 MARKET ECOSYSTEM
FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP
6.4.1 UPSTREAM
6.4.2 DOWNSTREAM
TABLE 5 COMPANY MARKET ECOSYSTEM
6.5 SUPPLY CHAIN ANALYSIS
FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET
6.5.1 R&D
6.5.2 PRODUCTION
6.5.3 PROCESSING & TRANSFORMING
6.5.4 TRANSPORTATION
6.5.5 FINAL PREPARATION
6.5.6 DISTRIBUTION
6.6 TECHNOLOGY ANALYSIS
6.7 PATENT ANALYSIS
FIGURE 33 PATENT ANALYSIS, 2017-2020
TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 2018- 2021
6.8 CASE STUDIES
TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION
6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET
FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES
6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS
6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT
6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY
7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
7.1 INTRODUCTION
FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021 VS. 2026 (USD MILLION)
TABLE 8 PATHOGENESIS OF COMMON PATHOGENS
FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019
TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019
TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
7.1.1.1 Realistic Scenario
TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1.2 Optimistic Scenario
TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.1.3 Pessimistic Scenario
TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)
7.1.2 E. COLI
7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning
FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–2018
FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)
TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.3 SALMONELLA
7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter
FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–2018
TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.4 CAMPYLOBACTER
7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness
FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018
TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.5 LISTERIA
7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen
TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
7.1.6 OTHER PATHOGENS
TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
8 ENTERIC DISEASE TESTING MARKET, BY END USE
8.1 INTRODUCTION
FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019
FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021 VS. 2026 (USD MILLION)
TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE
8.1.1.1 Realistic scenario
TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.1.1.2 Optimistic scenario
TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.1.1.3 Pessimistic scenario
TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
8.2 FOOD
8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING
TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS
FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017
TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES
TABLE 40 US: FOOD RECALLS, 2020
TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.2 MEAT, POULTRY, AND SEAFOOD
8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination
FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019
TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.3 DAIRY PRODUCTS
8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products
FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019
TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION)
TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION)
TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.4 PROCESSED FOOD
8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers
TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION)
TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, BY REGION, 2021–2026 (USD MILLION)
TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.5 FRUITS & VEGETABLES
8.2.5.1 Good handling practices can help in the safe production of fresh produce
TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2016–2020 (USD MILLION)
TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2021–2026 (USD MILLION)
TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2021–2026 (USD MILLION)
8.2.6 OTHER FOOD APPLICATIONS
TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2016–2020 (USD MILLION)
TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2021–2026 (USD MILLION)
8.3 WATER
8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS
TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2016–2020 (USD MILLION)
TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2021–2026 (USD MILLION)
TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2016–2020 (USD MILLION)
TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2021–2026 (USD MILLION)
9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
9.1.1.1 Realistic scenario
TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1.2 Optimistic scenario
TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.1.1.3 Pessimistic scenario
TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)
TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)
9.2 TRADITIONAL
9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE
TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
9.3 RAPID
TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, BY REGION, 2016–2020 (USD MILLION)
TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2021–2026 (USD MILLION)
9.3.1 CONVENIENCE-BASED
9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions
9.3.2 POLYMERASE CHAIN REACTION (PCR)
9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms
9.3.3 IMMUNOASSAY
9.3.3.1 ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies
9.3.4 CHROMATOGRAPHY & SPECTROMETRY
9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry
10 ENTERIC DISEASE TESTING MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020
FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026
TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION
10.1.1.1 Realistic scenario
TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1.2 Optimistic scenario
TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.1.1.3 Pessimistic scenario
TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)
TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.1 US
10.2.1.1 FSIS is the regulating body that enforces food safety regulations
FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018
FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016
TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)
FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016
TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety
TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.2.3 MEXICO
10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country
TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3 EUROPE
FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES
AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017
FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 International food trade has increased food safety risks
FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019
TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing
TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.3 SPAIN
10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry
TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Products of animal origin products are found to be more problematic in this region
TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.5 POLAND
10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety
TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENTS, 2016–2020 (USD MILLION)
TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.6 UK
10.3.6.1 Norovirus infection is estimated to occur every year in the UK
TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4 ASIA PACIFIC
TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 E. coli to be the major pathogen found to affect people
TABLE 150 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 151 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 152 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 153 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Microbial contamination is reported to be the biggest food safety risk
TABLE 154 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 155 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 156 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 157 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 FSSAI to safeguard the quality of food produced
TABLE 158 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 159 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 160 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 161 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.4 AUSTRALIA & NEW ZEALAND
10.4.4.1 Gastroenteritis occurs every year, affecting several people
TABLE 162 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 163 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 164 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 165 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.5 THAILAND
10.4.5.1 Demand for food exports to boost the growth of the market
TABLE 166 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 167 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 168 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 169 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 170 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 171 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5 SOUTH AMERICA
TABLE 174 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 175 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 176 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 177 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 178 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION)
TABLE 179 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Export of agricultural produce to boost the demand for enteric disease testing
TABLE 180 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 181 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 182 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 183 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.2 ARGENTINA
10.5.2.1 Food companies are taking preventive measures for pathogen infections
TABLE 184 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 185 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 186 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 187 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.5.3 REST OF SOUTH AMERICA
TABLE 188 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 189 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 190 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 191 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6 REST OF THE WORLD (ROW)
TABLE 192 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)
TABLE 193 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)
TABLE 194 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 195 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 196 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 197 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6.1 SOUTH AFRICA
10.6.1.1 Growth in the demand to follow international standards is encouraging enteric disease testing
TABLE 198 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 199 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 200 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 201 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
10.6.2 MIDDLE EAST
10.6.2.1 Food safety services are driven by food imports from other countries
TABLE 202 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)
TABLE 203 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)
TABLE 204 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)
TABLE 205 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET
11.3 MARKET SHARE ANALYSIS, 2020
FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS
11.4 COVID-19-SPECIFIC COMPANY RESPONSE
11.4.1 SGS SA
11.4.2 MERCK KGAA
11.4.3 EUROFINS SCIENTIFIC
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)
11.6 PRODUCT FOOTPRINT
TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY
TABLE 207 COMPANY FOOTPRINT, BY END-USE
TABLE 208 COMPANY FOOTPRINT, BY REGION
11.7 COMPANY EVALUATION QUADRANT (START-UP/SME)
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)
11.8 COMPETITIVE SCENARIO
11.8.1 NEW PRODUCTS LAUNCHES
TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019
11.8.2 DEALS
TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021
11.8.3 OTHER DEVELOPMENTS
TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, MAY 2018- JUNE 2021
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY COMPANIES
12.1.1 SGS SA
TABLE 212 SGS SA: BUSINESS OVERVIEW
FIGURE 59 SGS SA: COMPANY SNAPSHOT
TABLE 213 SGS SA: PRODUCT OFFERINGS
TABLE 214 SGA SA: DEALS
TABLE 215 SGS SA: OTHERS
12.1.2 MERCK KGAA
TABLE 216 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
TABLE 217 MERCK KGAA: PRODUCT OFFERINGS
12.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS
12.1.4 EUROFINS SCIENTIFIC
TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS
TABLE 223 EUROFINS SCIENTIFIC: DEALS
TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS
12.1.5 ALS LIMITED
TABLE 225 ALS LIMITED: BUSINESS OVERVIEW
FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT
TABLE 226 ALS LIMITED: PRODUCT OFFERINGS
TABLE 227 ALS LIMITED: DEALS
TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS
12.1.6 ASURE QUALITY
TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW
FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT
TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS
12.1.7 BUREAU VERITAS
TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW
FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT
TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS
12.1.8 INTERTEK
TABLE 233 INTERTEK: BUSINESS OVERVIEW
FIGURE 66 INTERTEK: COMPANY SNAPSHOT
TABLE 234 INTERTEK: PRODUCT OFFERINGS
TABLE 235 INTERTEK: DEALS
12.1.9 BIO-RAD LABORATORIES, INC.
TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
12.1.10 BECTON DICKINSON
TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW
FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT
TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS
12.1.11 3M
TABLE 240 3M: BUSINESS OVERVIEW
FIGURE 69 3M: COMPANY SNAPSHOT
TABLE 241 3M: PRODUCT OFFERINGS
12.1.12 PERKINELMER, INC.
TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS
12.1.13 NEOGEN CORPORATION
TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS
12.1.14 M?RIEUX NUTRISCIENCES
TABLE 246 M?RIEUX NUTRISCIENCES: BUSINESS OVERVIEW
TABLE 247 M?RIEUX NUTRISCIENCES: PRODUCT OFFERINGS
TABLE 248 M?RIEUX NUTRISCIENCES: DEALS
12.1.15 T?V S?D
TABLE 249 T?V S?D: BUSINESS OVERVIEW
TABLE 250 T?V S?D: PRODUCT OFFERINGS
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 HARDY DIAGNOSTICS
TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS
TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH
12.2.2 ROMER LABS
TABLE 254 ROMER LABS: BUSINESS OVERVIEW
TABLE 255 ROMER LABS: PRODUCT OFFERINGS
12.2.3 NOVA BIOLOGICALS
TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW
TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS
12.2.4 SYMBIO LABORATORIES
TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW
TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS
12.2.5 CERTIFIED LABORATORIES
13 ADJACENT AND RELATED MARKETS
13.1 INTRODUCTION
TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET
13.2 LIMITATIONS
13.3 FOOD PATHOGEN TESTING MARKET
13.3.1 MARKET DEFINITION
13.3.2 MARKET OVERVIEW
TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
13.4 FOOD TESTING KITS MARKET
13.4.1 MARKET DEFINITION
13.4.2 MARKET OVERVIEW
TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 2015–2022 (USD MILLION)
TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION)
13.5 MICROBIAL WATER TESTING MARKET
13.5.1 MARKET DEFINITION
13.5.2 MARKET OVERVIEW
TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION)
TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
